Highly Profitable Turnkey Pharmacy Operation
> Expected FY25 EBITDA circa $8m
> Expected FY25 Revenue circa $13m
> Consistent growth of circa 36% CAGR (FY22 to FY25)
This is a turnkey opportunity to acquire a fully licensed, highly profitable operation under full management. Since its inception, this company has developed a strong customer-driven referral network, with stellar word-of-mouth, fuelling its rapid and continued success.
The business operations include import/distribution, telehealth and pharmacy to provide a unique end-to-end vertical integration.
The company's efficient, lean business model makes it an attractive investment opportunity with significant growth potential, and strong opportunities for scaling and expansion.
Despite its well-established market presence and robust financial performance, significant expansion opportunities remain.
With an experienced team in place, this opportunity is well-suited to investors, strategic acquirers, and industry professionals looking to establish their footprint in the medical cannabis sector or expand their existing pharmaceutical portfolio.
Groves & Partners are inviting offers to acquire this exceptional business. Interested parties should contact Groves & Partners for further information.
